September 13, 2024
TOPLINE: A biosimilar demonstrated comparable efficacy and safety to aflibercept in treating diabetic macular edema. The vascular endothelial growth factor (VEGF) inhibitor was one of two […]
September 12, 2024
TOPLINE: Patients with ocular hypertension who develop primary open-angle glaucoma (POAG) without visual field loss did not experience a decreased vision-related quality of life compared with […]
September 10, 2024
An investigational gene therapy has shown promise for improving functional vision and restoring light detection in long-dormant rods and cones in the retina in adults and […]
September 10, 2024
(Reuters) -Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to […]
September 9, 2024
TOPLINE: Addressing vision impairments could help with dementia prevention, as vision impairment is linked to 19% of dementia cases in older adults. METHODOLOGY: Researchers conducted a […]
September 6, 2024
TOPLINE: In patients with proliferative diabetic retinopathy (PDR), treatment with panretinal photocoagulation (PRP) followed by anti–vascular endothelial growth factor (anti-VEGF) appears to increase complications and the […]
September 5, 2024
A policy change meant to reduce a backlog for cataract surgery in Ontario appears to have benefited wealthy patients, while reducing access to this critical treatment […]
August 27, 2024
TOPLINE: Elevated expression of the apolipoprotein E (APOE) gene is linked to corneal damage in patients with acute infection of the eye and shows high specificity […]
August 21, 2024
TOPLINE: Use of low-dose glucocorticoids after cataract surgery reduces the risk for secondary glaucoma in children with longer axial lengths over 5 years compared with high-dose […]